Eating Recovery Center/Pathlight Mood & Anxiety Center, Denver, CO, USA.
Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, Illinois, USA.
Eat Disord. 2024 Sep-Oct;32(5):493-508. doi: 10.1080/10640266.2024.2325296. Epub 2024 Mar 12.
The COVID-19 pandemic has required a shift to telehealth services. However, not all patients are similarly satisfied with this shift, with some studies finding that midlife and older adults are less comfortable with telehealth. The current study examined patient satisfaction with a virtual intensive outpatient program (VIOP) for eating disorders (EDs) among 305 adults (ages 18-25, ages 26-39, and ages 40+), and compared adult satisfaction to satisfaction among children/adolescents ( = 33) receiving VIOP treatment between August 2020 and March 2022 from a large ED treatment facility. It was hypothesized that adults aged 40+ would report lower satisfaction than younger age groups. Patients completed several questions regarding satisfaction with treatment upon discharge, including a question about likelihood of recommending the program, which was used to calculate a Net Promoter Score (NPS). The NPS was 33.3 for children/adolescents, 33.3 for 18-25 year-olds, 57.7 for 26-39 year-olds, and 30.9 for the 40+ year age group. NPS of 31-50 = quality services; 51-70 = excellent customer experiences. Satisfaction was high, with no statistically significant differences between age groups after Bonferroni correction. The current study adds to the limited literature on the treatment experiences of midlife adults with EDs.
译文:
新冠疫情 期间,远程医疗服务需求增加。然而,并非所有患者都对这种转变感到满意,一些研究发现,中年和老年患者对远程医疗的接受程度较低。本研究调查了 305 名成年人(18-25 岁、26-39 岁和 40 岁以上)对虚拟强化门诊项目(VIOP)治疗进食障碍的满意度,并将成年人的满意度与 2020 年 8 月至 2022 年 3 月期间在一家大型进食障碍治疗机构接受 VIOP 治疗的儿童/青少年( = 33)的满意度进行了比较。研究假设 40 岁以上的成年人的满意度会低于其他年龄组。患者在出院时完成了多项关于治疗满意度的问题,包括一项关于推荐该项目可能性的问题,该问题用于计算净推荐值(NPS)。儿童/青少年的 NPS 为 33.3,18-25 岁的 NPS 为 33.3,26-39 岁的 NPS 为 57.7,40 岁以上的 NPS 为 30.9。NPS 为 31-50 表示服务质量良好;NPS 为 51-70 表示客户体验优秀。经过 Bonferroni 校正后,各组之间没有统计学差异,满意度很高。本研究增加了关于中年进食障碍患者治疗体验的有限文献。